Camelus ferus isolate YT-003-E chromosome 34, BCGSAC_Cfer_1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Tylopoda; Camelidae; Camelus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020801.1.\nAssembly name: BCGSAC_Cfer_1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by The Bactrian Camels Genome\nSequencing and Analysis Consortium on 2020/01/08. The original\nwhole-genome shotgun project has the accession VSZR00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: The Bactrian Camels Genome Sequencing and\n Analysis Consortium\nAssembly Method :: FALCON v. FEB-2018; LACHESIS v. MAR-2018\nAssembly Name :: BCGSAC_Cfer_1.0\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 50.0x\nSequencing Technology :: PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Camelus ferus Annotation Release 102\nAnnotation Version :: 102\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.3\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC116661284, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC116661284, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
GDP-fucose protein O-fucosyltransferase 2-like isoform X2
GDP-fucose protein O-fucosyltransferase 2-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
glutamate receptor ionotropic, NMDA 2C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ALG10 alpha-1,2-glucosyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
ALG10 alpha-1,2-glucosyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase isoform X1
dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC116661377, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC116661377, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: dynamin-1-like protein
FYVE, RhoGEF and PH domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 4, transcript variant X4
FYVE, RhoGEF and PH domain containing 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 4 isoform X3
FYVE, RhoGEF and PH domain-containing protein 4 isoform X2
FYVE, RhoGEF and PH domain-containing protein 4 isoform X1
FYVE, RhoGEF and PH domain-containing protein 4 isoform X5
FYVE, RhoGEF and PH domain-containing protein 4 isoform X4
FYVE, RhoGEF and PH domain-containing protein 4 isoform X6
FYVE, RhoGEF and PH domain-containing protein 4 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
BICD cargo adaptor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BICD cargo adaptor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
BICD cargo adaptor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
retroelement silencing factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
retroelement silencing factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
retroelement silencing factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
retroelement silencing factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
retroelement silencing factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
retroelement silencing factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
retroelement silencing factor 1 isoform X3
retroelement silencing factor 1 isoform X2
retroelement silencing factor 1 isoform X1
retroelement silencing factor 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transfer RNA threonine (anticodon GGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
antagonist of mitotic exit network 1 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
antagonist of mitotic exit network 1 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
antagonist of mitotic exit network 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
electron transfer flavoprotein subunit beta lysine methyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
electron transfer flavoprotein subunit beta lysine methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
electron transfer flavoprotein subunit beta lysine methyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
electron transfer flavoprotein beta subunit lysine methyltransferase
DENN domain containing 5B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DENN domain containing 5B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
DENN domain-containing protein 5B isoform X1
DENN domain-containing protein 5B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
SIN3-HDAC complex associated factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
SIN3-HDAC complex associated factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SIN3-HDAC complex-associated factor isoform X2
SIN3-HDAC complex associated factor, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
SIN3-HDAC complex-associated factor isoform X3
SIN3-HDAC complex associated factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
SIN3-HDAC complex associated factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
SIN3-HDAC complex associated factor, transcript variant X5
SIN3-HDAC complex-associated factor isoform X1
caprin family member 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
caprin family member 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
caprin family member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
caprin family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
caprin family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
caprin family member 2, transcript variant X4
caprin family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
caprin family member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
caprin family member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
caprin family member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
caprin family member 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon GGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X5
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
transmembrane O-mannosyltransferase targeting cadherins 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein O-mannosyl-transferase TMTC1 isoform X1
protein O-mannosyl-transferase TMTC1 isoform X5
protein O-mannosyl-transferase TMTC1 isoform X2
protein O-mannosyl-transferase TMTC1 isoform X4
protein O-mannosyl-transferase TMTC1 isoform X3
protein O-mannosyl-transferase TMTC1 isoform X6
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
endoplasmic reticulum-Golgi intermediate compartment protein 2
fatty acyl-CoA reductase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fatty acyl-CoA reductase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fatty acyl-CoA reductase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fatty acyl-CoA reductase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acyl-CoA reductase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain containing 91, transcript variant X2
coiled-coil domain containing 91, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
coiled-coil domain containing 91, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
coiled-coil domain containing 91, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
coiled-coil domain containing 91, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
coiled-coil domain containing 91, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
coiled-coil domain-containing protein 91 isoform X2
coiled-coil domain-containing protein 91 isoform X5
coiled-coil domain-containing protein 91 isoform X6
coiled-coil domain-containing protein 91 isoform X1
coiled-coil domain-containing protein 91 isoform X4
coiled-coil domain-containing protein 91 isoform X3
parathyroid hormone like hormone, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
parathyroid hormone like hormone, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
parathyroid hormone like hormone, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
parathyroid hormone like hormone, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
parathyroid hormone like hormone, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
parathyroid hormone like hormone, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
parathyroid hormone-related protein isoform X1
parathyroid hormone-related protein isoform X2
transfer RNA glycine (anticodon ACC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC106730912, transcript variant X2
uncharacterized LOC106730912, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
MANSC domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
MANSC domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
28S ribosomal protein S35, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PPFIA binding protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X3
PPFIA binding protein 1, transcript variant X1
PPFIA binding protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PPFIA binding protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 35% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C12orf71 homolog
single-pass membrane protein with coiled-coil domains 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
single-pass membrane and coiled-coil domain-containing protein 2
uncharacterized LOC116661254, transcript variant X2
uncharacterized LOC116661254, transcript variant X1
aryl hydrocarbon receptor nuclear translocator like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator like 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aryl hydrocarbon receptor nuclear translocator-like protein 2 isoform X2
aryl hydrocarbon receptor nuclear translocator-like protein 2 isoform X1
aryl hydrocarbon receptor nuclear translocator-like protein 2 isoform X3
serine/threonine kinase 38 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
serine/threonine kinase 38 like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
mediator complex subunit 21, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mediator complex subunit 21, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mediator complex subunit 21, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mediator complex subunit 21, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator complex subunit 21, transcript variant X6
mediator complex subunit 21, transcript variant X2
mediator complex subunit 21, transcript variant X4
mediator complex subunit 21, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 21
transmembrane 7 superfamily member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transmembrane 7 superfamily member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
transmembrane 7 superfamily member 3 isoform X1
transmembrane 7 superfamily member 3 isoform X2
FGFR1 oncogene partner 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
FGFR1 oncogene partner 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
FGFR1 oncogene partner 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
FGFR1 oncogene partner 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
FGFR1 oncogene partner 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
integrator complex subunit 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
integrator complex subunit 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
integrator complex subunit 13 isoform X1
integrator complex subunit 13 isoform X2
serine/arginine repetitive matrix protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 90% coverage of the annotated genomic feature by RNAseq alignments
inositol 1,4,5-trisphosphate receptor type 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
transfer RNA valine (anticodon AAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ferritin light chain-like
basic helix-loop-helix family member e41, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
basic helix-loop-helix family member e41, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
basic helix-loop-helix family member e41, transcript variant X3
basic helix-loop-helix family member e41, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
basic helix-loop-helix family member e41, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
basic helix-loop-helix family member e41, transcript variant X7
basic helix-loop-helix family member e41, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
class E basic helix-loop-helix protein 41 isoform X1
class E basic helix-loop-helix protein 41 isoform X2
Ras association domain family member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Ras association domain family member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Ras association domain family member 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ras association domain-containing protein 8
lamin tail domain containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lamin tail domain containing 1, transcript variant X3
lamin tail domain containing 1, transcript variant X4
lamin tail domain containing 1, transcript variant X8
lamin tail domain containing 1, transcript variant X10
lamin tail domain containing 1, transcript variant X11
lamin tail domain containing 1, transcript variant X12
lamin tail domain containing 1, transcript variant X13
lamin tail domain containing 1, transcript variant X19
lamin tail domain containing 1, transcript variant X14
lamin tail domain containing 1, transcript variant X15
lamin tail domain containing 1, transcript variant X16
lamin tail domain containing 1, transcript variant X1
lamin tail domain containing 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lamin tail domain containing 1, transcript variant X6
lamin tail domain containing 1, transcript variant X2
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
lamin tail domain containing 1, transcript variant X7
lamin tail domain-containing protein 1 isoform X1
lamin tail domain-containing protein 1 isoform X2
lamin tail domain containing 1, transcript variant X20
lamin tail domain containing 1, transcript variant X18
lamin tail domain-containing protein 1 isoform X4
lamin tail domain containing 1, transcript variant X17
lamin tail domain-containing protein 1 isoform X3
lamin tail domain-containing protein 1 isoform X5
uncharacterized LOC116661281, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC116661281, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC116661281, transcript variant X8
uncharacterized LOC116661281, transcript variant X7
uncharacterized LOC116661281, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC116661281, transcript variant X12
uncharacterized LOC116661281, transcript variant X4
uncharacterized LOC116661281, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC116661281, transcript variant X11
uncharacterized LOC116661281, transcript variant X13
uncharacterized LOC116661281, transcript variant X14
uncharacterized LOC116661281, transcript variant X9
uncharacterized LOC116661281, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC116661281, transcript variant X3
KRAS proto-oncogene, GTPase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
KRAS proto-oncogene, GTPase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
KRAS proto-oncogene, GTPase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
KRAS proto-oncogene, GTPase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X14
electron transfer flavoprotein regulatory factor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X4
electron transfer flavoprotein regulatory factor 1, transcript variant X3
electron transfer flavoprotein regulatory factor 1, transcript variant X8
electron transfer flavoprotein regulatory factor 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1, transcript variant X7
electron transfer flavoprotein regulatory factor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
electron transfer flavoprotein regulatory factor 1
cancer susceptibility 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cancer susceptibility 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cancer susceptibility 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cancer susceptibility 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cancer susceptibility 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cancer susceptibility 1, transcript variant X1
cancer susceptibility 1, transcript variant X7
lymphoid restricted membrane protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
lymphoid restricted membrane protein, transcript variant X1
lymphoid restricted membrane protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lymphoid-restricted membrane protein isoform X3
lymphoid-restricted membrane protein isoform X1
lymphoid-restricted membrane protein isoform X2
branched chain amino acid transaminase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
branched chain amino acid transaminase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
branched-chain-amino-acid aminotransferase, cytosolic isoform X1
branched-chain-amino-acid aminotransferase, cytosolic isoform X2
branched chain amino acid transaminase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
branched-chain-amino-acid aminotransferase, cytosolic isoform X3
branched chain amino acid transaminase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
branched-chain-amino-acid aminotransferase, cytosolic isoform X4
SRY-box transcription factor 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
SRY-box transcription factor 5, transcript variant X3
SRY-box transcription factor 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
SRY-box transcription factor 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SRY-box transcription factor 5, transcript variant X5
SRY-box transcription factor 5, transcript variant X8
SRY-box transcription factor 5, transcript variant X1
SRY-box transcription factor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
SRY-box transcription factor 5, transcript variant X9
SRY-box transcription factor 5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
SRY-box transcription factor 5, transcript variant X11
transfer RNA asparagine (anticodon AUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X4
C2 calcium dependent domain containing 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X3
C2 calcium dependent domain containing 5, transcript variant X7
C2 calcium dependent domain containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
C2 calcium dependent domain containing 5, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
C2 domain-containing protein 5 isoform X4
C2 domain-containing protein 5 isoform X1
C2 domain-containing protein 5 isoform X3
C2 domain-containing protein 5 isoform X7
C2 domain-containing protein 5 isoform X2
C2 domain-containing protein 5 isoform X5
C2 domain-containing protein 5 isoform X8
C2 domain-containing protein 5 isoform X6
C2 domain-containing protein 5 isoform X9
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-N-acetylneuraminide alpha-2,8-sialyltransferase isoform X1
alpha-N-acetylneuraminide alpha-2,8-sialyltransferase isoform X2
alpha-N-acetylneuraminide alpha-2,8-sialyltransferase isoform X4
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
alpha-N-acetylneuraminide alpha-2,8-sialyltransferase isoform X3
cytidine monophosphate N-acetylneuraminic acid synthetase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
ATP binding cassette subfamily C member 9
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ATP-binding cassette sub-family C member 9
potassium inwardly rectifying channel subfamily J member 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ATP-sensitive inward rectifier potassium channel 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 mRNAs, 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
glycogen synthase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glycogen synthase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glycogen [starch] synthase, liver isoform X1
glycogen [starch] synthase, liver isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
RecQ like helicase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
RecQ like helicase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
RecQ like helicase, transcript variant X3
ATP-dependent DNA helicase Q1 isoform X1
ATP-dependent DNA helicase Q1 isoform X2
pyridine nucleotide-disulphide oxidoreductase domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
pyridine nucleotide-disulphide oxidoreductase domain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 isoform X2
pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 isoform X1
solute carrier organic anion transporter family member 1A2, transcript variant X1
solute carrier organic anion transporter family member 1A2, transcript variant X4
solute carrier organic anion transporter family member 1A2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier organic anion transporter family member 1A2, transcript variant X6
solute carrier organic anion transporter family member 1A2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: islet amyloid polypeptide
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
solute carrier organic anion transporter family member 1A2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier organic anion transporter family member 1A2
solute carrier organic anion transporter family member 1B1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier organic anion transporter family member 1C1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
phosphodiesterase 3A, transcript variant X4
phosphodiesterase 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
phosphodiesterase 3A, transcript variant X5
phosphodiesterase 3A, transcript variant X2
phosphodiesterase 3A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X1
cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X2
cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X3
cGMP-inhibited 3',5'-cyclic phosphodiesterase A isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein AEBP2
pleckstrin homology domain containing A5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X2
pleckstrin homology domain containing A5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X5
pleckstrin homology domain containing A5, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
pleckstrin homology domain containing A5, transcript variant X9
pleckstrin homology domain containing A5, transcript variant X6
pleckstrin homology domain-containing family A member 5 isoform X10
pleckstrin homology domain-containing family A member 5 isoform X8
pleckstrin homology domain-containing family A member 5 isoform X14
pleckstrin homology domain-containing family A member 5 isoform X13
pleckstrin homology domain-containing family A member 5 isoform X2
pleckstrin homology domain-containing family A member 5 isoform X9
pleckstrin homology domain-containing family A member 5 isoform X7
pleckstrin homology domain-containing family A member 5 isoform X3
pleckstrin homology domain-containing family A member 5 isoform X5
pleckstrin homology domain-containing family A member 5 isoform X1
pleckstrin homology domain-containing family A member 5 isoform X6
pleckstrin homology domain containing A5, transcript variant X4
pleckstrin homology domain-containing family A member 5 isoform X4
pleckstrin homology domain containing A5, transcript variant X12
pleckstrin homology domain-containing family A member 5 isoform X11
pleckstrin homology domain containing A5, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 5 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
capping actin protein of muscle Z-line subunit alpha 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins
phospholipase C zeta 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
phospholipase C zeta 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 isoform X2
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma isoform X3
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma isoform X2
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma isoform X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X4
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X6
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
LIM domain only 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LIM domain only 3, transcript variant X9
LIM domain only 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LIM domain only 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
LIM domain only 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LIM domain only 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
LIM domain only 3, transcript variant X2
LIM domain only 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
LIM domain only 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LIM domain only 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC116661295, transcript variant X3
uncharacterized LOC116661295, transcript variant X8
uncharacterized LOC116661295, transcript variant X9
uncharacterized LOC116661295, transcript variant X6
uncharacterized LOC116661295, transcript variant X5
uncharacterized LOC116661295, transcript variant X4
uncharacterized LOC116661295, transcript variant X2
uncharacterized LOC116661295, transcript variant X7
uncharacterized LOC116661295, transcript variant X1
uncharacterized LOC116661295, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
deoxyribose-phosphate aldolase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
deoxyribose-phosphate aldolase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
deoxyribose-phosphate aldolase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
deoxyribose-phosphate aldolase isoform X2
deoxyribose-phosphate aldolase isoform X1
serine/threonine kinase receptor associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
serine-threonine kinase receptor-associated protein
COORDINATES: nucleotide motif:Rfam:12.0:RF00319
uncharacterized LOC116661302, transcript variant X2
uncharacterized LOC116661302, transcript variant X1
epidermal growth factor receptor pathway substrate 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 8, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 8, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
epidermal growth factor receptor kinase substrate 8 isoform X2
epidermal growth factor receptor pathway substrate 8, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
epidermal growth factor receptor pathway substrate 8, transcript variant X4
epidermal growth factor receptor kinase substrate 8 isoform X1
protein tyrosine phosphatase receptor type O, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase receptor type O, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
receptor-type tyrosine-protein phosphatase O isoform X2
receptor-type tyrosine-protein phosphatase O isoform X1
RAS like estrogen regulated growth inhibitor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RAS like estrogen regulated growth inhibitor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor isoform X2
ras-related and estrogen-regulated growth inhibitor isoform X3
RAS like estrogen regulated growth inhibitor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
ras-related and estrogen-regulated growth inhibitor isoform X1
phosphodiesterase 6H, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphodiesterase 6H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphodiesterase 6H, transcript variant X3
retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
endoplasmic reticulum resident protein 27
chromosome 34 C12orf60 homolog, transcript variant X2
chromosome 34 C12orf60 homolog, transcript variant X6
chromosome 34 C12orf60 homolog, transcript variant X8
chromosome 34 C12orf60 homolog, transcript variant X11
chromosome 34 C12orf60 homolog, transcript variant X10
chromosome 34 C12orf60 homolog, transcript variant X12
chromosome 34 C12orf60 homolog, transcript variant X9
chromosome 34 C12orf60 homolog, transcript variant X7
chromosome 34 C12orf60 homolog, transcript variant X5
chromosome 34 C12orf60 homolog, transcript variant X4
chromosome 34 C12orf60 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
ADP-ribosyltransferase 4 (Dombrock blood group)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
chromosome 34 C12orf60 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein C12orf60 homolog
single-pass membrane protein with coiled-coil domains 3
single-pass membrane and coiled-coil domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LOW QUALITY PROTEIN: heat-stable enterotoxin receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
activating transcription factor 7 interacting protein
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: activating transcription factor 7-interacting protein 1
glutamate ionotropic receptor NMDA type subunit 2B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC116661361, transcript variant X2
uncharacterized LOC116661361, transcript variant X1
germ cell associated 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
germ cell associated 1, transcript variant X1
germ cell associated 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
germ cell associated 1, transcript variant X5
germ cell-specific gene 1 protein isoform X1
germ cell-specific gene 1 protein isoform X4
germ cell-specific gene 1 protein isoform X5
germ cell associated 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
germ cell-specific gene 1 protein isoform X2
germ cell-specific gene 1 protein isoform X3
family with sequence similarity 234 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
G protein-coupled receptor class C group 5 member D, transcript variant X1
G protein-coupled receptor class C group 5 member D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
G-protein coupled receptor family C group 5 member D isoform X1
G-protein coupled receptor family C group 5 member D isoform X2
G protein-coupled receptor class C group 5 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX47
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
apolipoprotein L domain-containing protein 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X8
G protein-coupled receptor 19, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
G protein-coupled receptor 19, transcript variant X6
probable G-protein coupled receptor 19 isoform X1
probable G-protein coupled receptor 19 isoform X2
cAMP responsive element binding protein like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
cAMP-responsive element-binding protein-like 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
BLOC-1 related complex subunit 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
BLOC-1 related complex subunit 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
BLOC-1 related complex subunit 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
BLOC-1 related complex subunit 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
BLOC-1-related complex subunit 5 isoform X3
BLOC-1-related complex subunit 5 isoform X4
BLOC-1-related complex subunit 5 isoform X2
BLOC-1-related complex subunit 5 isoform X1
MANSC domain containing 1, transcript variant X2
MANSC domain containing 1, transcript variant X1
MANSC domain-containing protein 1 isoform X1
MANSC domain-containing protein 1 isoform X2
LDL receptor related protein 6, transcript variant X3
LDL receptor related protein 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
LDL receptor related protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
low-density lipoprotein receptor-related protein 6 isoform X1
low-density lipoprotein receptor-related protein 6 isoform X3
low-density lipoprotein receptor-related protein 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
apoptosis facilitator Bcl-2-like protein 14 isoform X1
apoptosis facilitator Bcl-2-like protein 14 isoform X2
ETS variant transcription factor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ETS variant transcription factor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
ETS variant transcription factor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: taste receptor type 2 member 42
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
small integral membrane protein 10 like 1
small integral membrane protein 10-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
LOW QUALITY PROTEIN: Y-box-binding protein 3
serine/threonine/tyrosine kinase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine/tyrosine kinase 1, transcript variant X3
serine/threonine/tyrosine kinase 1, transcript variant X6
serine/threonine/tyrosine kinase 1, transcript variant X2
serine/threonine/tyrosine kinase 1, transcript variant X4
serine/threonine/tyrosine kinase 1, transcript variant X1
tyrosine-protein kinase STYK1 isoform X1
tyrosine-protein kinase STYK1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
mago homolog B, exon junction complex subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
killer cell lectin-like receptor 2, transcript variant X1
killer cell lectin-like receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
killer cell lectin-like receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
killer cell lectin-like receptor 2, transcript variant X4
natural killer cells antigen CD94-like, transcript variant X2
natural killer cells antigen CD94-like, transcript variant X1
natural killer cells antigen CD94-like isoform X1
natural killer cells antigen CD94-like isoform X2
C-type lectin domain family 12 member B-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: C-type lectin domain family 12 member B-like
killer cell lectin-like receptor subfamily I member 1, transcript variant X1
killer cell lectin-like receptor subfamily I member 1, transcript variant X3
killer cell lectin-like receptor subfamily I member 1, transcript variant X2
killer cell lectin-like receptor subfamily I member 1 isoform X1
killer cell lectin-like receptor subfamily I member 1 isoform X2
NKG2-A/NKG2-B type II integral membrane protein-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: NKG2-A/NKG2-B type II integral membrane protein-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 14 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: NKG2-D type II integral membrane protein
natural killer cells antigen CD94, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
natural killer cells antigen CD94, transcript variant X1
natural killer cells antigen CD94, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
natural killer cells antigen CD94, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
natural killer cells antigen CD94, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
natural killer cells antigen CD94 isoform X2
natural killer cells antigen CD94 isoform X1
natural killer cells antigen CD94 isoform X4
natural killer cells antigen CD94 isoform X3
killer cell lectin-like receptor subfamily E member 1, transcript variant X12
killer cell lectin-like receptor subfamily E member 1, transcript variant X3
killer cell lectin-like receptor subfamily E member 1 isoform X2
killer cell lectin-like receptor subfamily E member 1, transcript variant X9
killer cell lectin-like receptor subfamily E member 1, transcript variant X10
killer cell lectin-like receptor subfamily E member 1, transcript variant X7
killer cell lectin-like receptor subfamily E member 1, transcript variant X6
killer cell lectin-like receptor subfamily E member 1 isoform X5
killer cell lectin-like receptor subfamily E member 1 isoform X6
killer cell lectin-like receptor subfamily E member 1, transcript variant X11
killer cell lectin-like receptor subfamily E member 1, transcript variant X4
killer cell lectin-like receptor subfamily E member 1 isoform X3
killer cell lectin-like receptor subfamily E member 1, transcript variant X5
killer cell lectin-like receptor subfamily E member 1, transcript variant X8
killer cell lectin-like receptor subfamily E member 1, transcript variant X2
killer cell lectin-like receptor subfamily E member 1, transcript variant X1
killer cell lectin-like receptor subfamily E member 1 isoform X4
killer cell lectin-like receptor subfamily E member 1 isoform X1
killer cell lectin-like receptor subfamily E member 1 isoform X7
gamma-aminobutyric acid receptor-associated protein-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
transmembrane protein 52B, transcript variant X1
transmembrane protein 52B, transcript variant X2
transmembrane protein 52B, transcript variant X3
oxidized low density lipoprotein receptor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
oxidized low-density lipoprotein receptor 1
C-type lectin domain containing 7A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
C-type lectin domain containing 7A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
C-type lectin domain containing 7A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
C-type lectin domain containing 7A, transcript variant X2
C-type lectin domain family 7 member A isoform X1
C-type lectin domain family 7 member A isoform X3
C-type lectin domain family 7 member A isoform X4
C-type lectin domain family 7 member A isoform X2
C-type lectin domain family 1 member A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
C-type lectin domain family 1 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
C-type lectin domain family 1 member A, transcript variant X1
C-type lectin domain family 1 member A isoform X1
C-type lectin domain family 1 member A, transcript variant X3
C-type lectin domain family 1 member A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
C-type lectin domain family 1 member A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C-type lectin domain family 1 member B, transcript variant X2
C-type lectin domain family 1 member B, transcript variant X1
C-type lectin domain family 1 member B isoform X2
C-type lectin domain family 1 member B isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: C-type lectin domain family 12 member B
C-type lectin domain family 12 member A, transcript variant X2
C-type lectin domain family 12 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
C-type lectin domain family 2 member A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C-type lectin domain family 2 member A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-type lectin domain family 2 member A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
C-type lectin domain family 2 member A, transcript variant X2
C-type lectin domain family 2 member A isoform X1
C-type lectin domain family 2 member A isoform X2
killer cell lectin like receptor F2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
killer cell lectin like receptor F2, transcript variant X1
killer cell lectin-like receptor subfamily F member 2 isoform X2
killer cell lectin-like receptor subfamily F member 2 isoform X1
C-type lectin domain family 2 member B, transcript variant X1
C-type lectin domain family 2 member B, transcript variant X4
C-type lectin domain family 2 member B, transcript variant X2
C-type lectin domain family 2 member B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
C-type lectin domain family 2 member B isoform X2
C-type lectin domain family 2 member B isoform X1
killer cell lectin like receptor F1, transcript variant X3
killer cell lectin like receptor F1, transcript variant X2
killer cell lectin like receptor F1, transcript variant X1
killer cell lectin-like receptor subfamily F member 1 isoform X3
killer cell lectin-like receptor subfamily F member 1 isoform X2
killer cell lectin-like receptor subfamily F member 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
C-type lectin domain family 2 member A-like, transcript variant X1
C-type lectin domain family 2 member A-like, transcript variant X2
C-type lectin domain family 2 member A-like, transcript variant X9
C-type lectin domain family 2 member A-like, transcript variant X7
C-type lectin domain family 2 member A-like, transcript variant X4
C-type lectin domain family 2 member A-like, transcript variant X5
C-type lectin domain family 2 member A-like, transcript variant X6
C-type lectin domain family 2 member A-like, transcript variant X3
C-type lectin domain family 2 member A-like, transcript variant X8
C-type lectin domain family 2 member A-like isoform X1
C-type lectin domain family 2 member F-like isoform X2
killer cell lectin-like receptor subfamily B member 1B allele A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
killer cell lectin-like receptor subfamily B member 1B allele A, transcript variant X1
killer cell lectin-like receptor subfamily B member 1B allele A, transcript variant X3
killer cell lectin-like receptor subfamily B member 1B allele A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC116661270, transcript variant X2
uncharacterized LOC116661270, transcript variant X3
uncharacterized LOC116661270, transcript variant X1
killer cell lectin like receptor B1, transcript variant X1
killer cell lectin like receptor B1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
killer cell lectin like receptor B1, transcript variant X3
killer cell lectin-like receptor subfamily B member 1 isoform X1
killer cell lectin-like receptor subfamily B member 1 isoform X2
killer cell lectin-like receptor subfamily B member 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
killer cell lectin like receptor G1, transcript variant X1
killer cell lectin-like receptor subfamily G member 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 20 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
killer cell lectin like receptor G1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
killer cell lectin-like receptor subfamily G member 1 isoform X3
killer cell lectin like receptor G1, transcript variant X2
killer cell lectin-like receptor subfamily G member 1 isoform X2
mannose-6-phosphate receptor, cation dependent, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
mannose-6-phosphate receptor, cation dependent, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
cation-dependent mannose-6-phosphate receptor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LOW QUALITY PROTEIN: polyhomeotic-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
alpha-2-macroglobulin like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
alpha-2-macroglobulin like 1, transcript variant X1
ribosomal modification protein rimK like family member B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ribosomal modification protein rimK like family member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ribosomal modification protein rimK like family member B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ribosomal modification protein rimK like family member B, transcript variant X3
ribosomal modification protein rimK like family member B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ribosomal modification protein rimK like family member B, transcript variant X4
microfibril associated protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
microfibril associated protein 5, transcript variant X1
microfibrillar-associated protein 5 isoform X2
microfibrillar-associated protein 5 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
apolipoprotein B mRNA editing enzyme catalytic subunit 1
developmental pluripotency-associated protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 2 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 2 member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 2 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
solute carrier family 2 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
solute carrier family 2, facilitated glucose transporter member 3 isoform X1
solute carrier family 2, facilitated glucose transporter member 3 isoform X2
solute carrier family 2, facilitated glucose transporter member 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
adaptin ear-binding coat-associated protein 1
C-type lectin domain family 4 member D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
C-type lectin domain family 4 member D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
C-type lectin domain family 4 member D isoform X1
C-type lectin domain family 4 member D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
scavenger receptor cysteine-rich type 1 protein M130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
scavenger receptor cysteine-rich type 1 protein M130, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
scavenger receptor cysteine-rich type 1 protein M130 isoform X1
scavenger receptor cysteine-rich type 1 protein M130 isoform X2
antigen WC1.1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
antigen WC1.1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 50 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
peroxisomal biogenesis factor 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
peroxisomal biogenesis factor 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
peroxisomal biogenesis factor 5 isoform X1
peroxisomal biogenesis factor 5 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC116661253, transcript variant X3
uncharacterized LOC116661253, transcript variant X2
uncharacterized LOC116661253, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
lysophosphatidylcholine acyltransferase 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
EMG1 N1-specific pseudouridine methyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
EMG1 N1-specific pseudouridine methyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ribosomal RNA small subunit methyltransferase NEP1 isoform X2
ribosomal RNA small subunit methyltransferase NEP1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF01294
protein tyrosine phosphatase non-receptor type 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 6 isoform X1
tyrosine-protein phosphatase non-receptor type 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00066
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
leucine rich repeat containing 23, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
leucine-rich repeat-containing protein 23 isoform X4
leucine rich repeat containing 23, transcript variant X7
leucine rich repeat containing 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat containing 23, transcript variant X4
leucine rich repeat containing 23, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
leucine rich repeat containing 23, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine rich repeat containing 23, transcript variant X5
leucine rich repeat containing 23, transcript variant X3
leucine-rich repeat-containing protein 23 isoform X3
leucine-rich repeat-containing protein 23 isoform X2
leucine-rich repeat-containing protein 23 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
splA/ryanodine receptor domain and SOCS box containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
ubiquitin specific peptidase 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
ubiquitin specific peptidase 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 5 isoform X2
ubiquitin carboxyl-terminal hydrolase 5 isoform X1
cell division cycle associated 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cell division cycle associated 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cell division cycle-associated protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
prolyl 3-hydroxylase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
prolyl 3-hydroxylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
G protein-coupled receptor 162, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
G protein-coupled receptor 162, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
G protein-coupled receptor 162, transcript variant X2
probable G-protein coupled receptor 162 isoform X1
probable G-protein coupled receptor 162 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
proline-rich receptor-like protein kinase PERK8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
COP9 signalosome subunit 7A, transcript variant X2
COP9 signalosome complex subunit 7a isoform X2
COP9 signalosome subunit 7A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
COP9 signalosome subunit 7A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
COP9 signalosome subunit 7A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
COP9 signalosome complex subunit 7a isoform X1
COP9 signalosome complex subunit 7a isoform X3
PILR alpha associated neural protein, transcript variant X1
PILR alpha associated neural protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PILR alpha associated neural protein, transcript variant X3
zinc finger protein 384, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
zinc finger protein 384, transcript variant X4
zinc finger protein 384, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
zinc finger protein 384, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
zinc finger protein 384, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
zinc finger protein 384, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
zinc finger protein 384, transcript variant X7
zinc finger protein 384, transcript variant X2
zinc finger protein 384, transcript variant X5
zinc finger protein 384, transcript variant X6
inhibitor of growth family member 4, transcript variant X9
inhibitor of growth family member 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X1
inhibitor of growth family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
inhibitor of growth family member 4, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
inhibitor of growth protein 4 isoform X1
inhibitor of growth protein 4 isoform X3
inhibitor of growth protein 4 isoform X2
inhibitor of growth protein 4 isoform X4
inhibitor of growth protein 4 isoform X5
inhibitor of growth protein 4 isoform X7
inhibitor of growth protein 4 isoform X6
inhibitor of growth protein 4 isoform X8
inhibitor of growth protein 4 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysophosphatidic acid receptor 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
lysophosphatidic acid receptor 5, transcript variant X3
lysophosphatidic acid receptor 5, transcript variant X2
lysophosphatidic acid receptor 5, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
lysophosphatidic acid receptor 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lysophosphatidic acid receptor 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
lysophosphatidic acid receptor 5, transcript variant X7
chromodomain helicase DNA binding protein 4, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X10
chromodomain helicase DNA binding protein 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
chromodomain helicase DNA binding protein 4, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
chromodomain-helicase-DNA-binding protein 4 isoform X1
chromodomain-helicase-DNA-binding protein 4 isoform X2
chromodomain-helicase-DNA-binding protein 4 isoform X4
chromodomain-helicase-DNA-binding protein 4 isoform X5
chromodomain-helicase-DNA-binding protein 4 isoform X8
chromodomain-helicase-DNA-binding protein 4 isoform X6
chromodomain-helicase-DNA-binding protein 4 isoform X7
chromodomain-helicase-DNA-binding protein 4 isoform X3
chromodomain-helicase-DNA-binding protein 4 isoform X9
chromodomain-helicase-DNA-binding protein 4 isoform X13
chromodomain-helicase-DNA-binding protein 4 isoform X12
chromodomain-helicase-DNA-binding protein 4 isoform X10
chromodomain-helicase-DNA-binding protein 4 isoform X11
chromodomain-helicase-DNA-binding protein 4 isoform X14
COORDINATES: nucleotide motif:Rfam:12.0:RF00564
uncharacterized LOC116661272, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC116661272, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase
intermediate filament family orphan 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
intermediate filament family orphan 1, transcript variant X11
intermediate filament family orphan 1, transcript variant X4
intermediate filament family orphan 1, transcript variant X1
intermediate filament family orphan 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
intermediate filament family orphan 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
intermediate filament family orphan 1, transcript variant X7
intermediate filament family orphan 1, transcript variant X2
intermediate filament family orphan 1, transcript variant X6
intermediate filament family orphan 1, transcript variant X8
intermediate filament family orphan 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
intermediate filament family orphan 1 isoform X1
intermediate filament family orphan 1 isoform X3
intermediate filament family orphan 1 isoform X5
intermediate filament family orphan 1 isoform X7
intermediate filament family orphan 1 isoform X2
intermediate filament family orphan 1 isoform X6
intermediate filament family orphan 1 isoform X8
intermediate filament family orphan 1 isoform X9
intermediate filament family orphan 1 isoform X4
intermediate filament family orphan 1 isoform X10
intermediate filament family orphan 1 isoform X11
glyceraldehyde-3-phosphate dehydrogenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 mRNAs, 72 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
non-SMC condensin I complex subunit D2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
non-SMC condensin I complex subunit D2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
non-SMC condensin I complex subunit D2, transcript variant X2
non-SMC condensin I complex subunit D2, transcript variant X1
non-SMC condensin I complex subunit D2, transcript variant X4
COORDINATES: nucleotide motif:Rfam:12.0:RF01296
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
39S ribosomal protein L51, mitochondrial
sodium channel epithelial 1 subunit alpha, transcript variant X9
sodium channel epithelial 1 subunit alpha, transcript variant X11
sodium channel epithelial 1 subunit alpha, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
amiloride-sensitive sodium channel subunit alpha isoform X1
amiloride-sensitive sodium channel subunit alpha isoform X8
amiloride-sensitive sodium channel subunit alpha isoform X7
amiloride-sensitive sodium channel subunit alpha isoform X6
amiloride-sensitive sodium channel subunit alpha isoform X9
amiloride-sensitive sodium channel subunit alpha isoform X11
amiloride-sensitive sodium channel subunit alpha isoform X10
TAP binding protein like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
TAP binding protein like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
TAP binding protein like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
TAP binding protein like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
LOW QUALITY PROTEIN: tumor necrosis factor receptor superfamily member 3
sodium channel epithelial 1 subunit alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
amiloride-sensitive sodium channel subunit alpha isoform X2
sodium channel epithelial 1 subunit alpha, transcript variant X3
amiloride-sensitive sodium channel subunit alpha isoform X3
sodium channel epithelial 1 subunit alpha, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sodium channel epithelial 1 subunit alpha, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
amiloride-sensitive sodium channel subunit alpha isoform X4
sodium channel epithelial 1 subunit alpha, transcript variant X7
sodium channel epithelial 1 subunit alpha, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
amiloride-sensitive sodium channel subunit alpha isoform X5
TNF receptor superfamily member 1A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
TNF receptor superfamily member 1A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
TNF receptor superfamily member 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
tumor necrosis factor receptor superfamily member 1A isoform X1
tumor necrosis factor receptor superfamily member 1A isoform X2
tumor necrosis factor receptor superfamily member 1A isoform X3
pleckstrin homology and RhoGEF domain containing G6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
pleckstrin homology and RhoGEF domain containing G6, transcript variant X2
pleckstrin homology domain-containing family G member 6
uncharacterized LOC116661367, transcript variant X2
uncharacterized LOC116661367, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
LOW QUALITY PROTEIN: von Willebrand factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: potassium voltage-gated channel subfamily A member 5
uncharacterized LOC106728536, transcript variant X1
uncharacterized LOC106728536, transcript variant X2
potassium voltage-gated channel subfamily A member 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: potassium voltage-gated channel subfamily A member 1
potassium voltage-gated channel subfamily A member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
potassium voltage-gated channel subfamily A member 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel subfamily A member 6, transcript variant X2
potassium voltage-gated channel subfamily A member 6
NADH:ubiquinone oxidoreductase subunit A9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 3 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: A-kinase anchor protein 3
dual specificity tyrosine phosphorylation regulated kinase 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LOW QUALITY PROTEIN: dual specificity tyrosine-phosphorylation-regulated kinase 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
chromosome 34 C12orf4 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
chromosome 34 C12orf4 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
chromosome 34 C12orf4 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
chromosome 34 C12orf4 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
chromosome 34 C12orf4 homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TP53 induced glycolysis regulatory phosphatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
TP53 induced glycolysis regulatory phosphatase, transcript variant X3
TP53 induced glycolysis regulatory phosphatase, transcript variant X1
fructose-2,6-bisphosphatase TIGAR isoform X2
fructose-2,6-bisphosphatase TIGAR isoform X3
fructose-2,6-bisphosphatase TIGAR isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
poly(ADP-ribose) polymerase family member 11, transcript variant X2
poly(ADP-ribose) polymerase family member 11, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
poly(ADP-ribose) polymerase family member 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
protein mono-ADP-ribosyltransferase PARP11
calcium release activated channel regulator 2A
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LOW QUALITY PROTEIN: EF-hand calcium-binding domain-containing protein 4B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: protein arginine N-methyltransferase 8
uncharacterized LOC116661335, transcript variant X2
uncharacterized LOC116661335, transcript variant X3
uncharacterized LOC116661335, transcript variant X5
uncharacterized LOC116661335, transcript variant X4
uncharacterized LOC116661335, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
TEA domain transcription factor 4, transcript variant X2
TEA domain transcription factor 4, transcript variant X1
TEA domain transcription factor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TEA domain transcription factor 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transcriptional enhancer factor TEF-3 isoform X1
transcriptional enhancer factor TEF-3 isoform X3
transcriptional enhancer factor TEF-3 isoform X2
transcriptional enhancer factor TEF-3 isoform X4
TEA domain transcription factor 4, transcript variant X4
TUB like protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TUB like protein 3, transcript variant X5
TUB like protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
TUB like protein 3, transcript variant X6
TUB like protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
TUB like protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
TUB like protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAD9-HUS1-RAD1 interacting nuclear orphan 1, transcript variant X1
RAD9-HUS1-RAD1 interacting nuclear orphan 1, transcript variant X2
RAD9-HUS1-RAD1 interacting nuclear orphan 1, transcript variant X3
RAD9, HUS1, RAD1-interacting nuclear orphan protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LOW QUALITY PROTEIN: forkhead box protein M1
testis expressed 52, transcript variant X1
testis expressed 52, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
integrin alpha FG-GAP repeat containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
integrin alpha FG-GAP repeat containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
KICSTOR complex protein ITFG2 isoform X2
KICSTOR complex protein ITFG2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 mRNAs, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase FKBP4
maestro heat-like repeat-containing protein family member 1, transcript variant X1
maestro heat-like repeat-containing protein family member 1, transcript variant X2
maestro heat-like repeat-containing protein family member 1, transcript variant X3
maestro heat-like repeat-containing protein family member 1, transcript variant X4
maestro heat-like repeat-containing protein family member 1, transcript variant X5
maestro heat-like repeat-containing protein family member 1 isoform X1
maestro heat-like repeat-containing protein family member 1 isoform X2
maestro heat-like repeat-containing protein family member 1 isoform X3
maestro heat-like repeat-containing protein family member 1 isoform X4
maestro heat-like repeat-containing protein family member 1 isoform X5
DEAD/H-box helicase 11, transcript variant X3
DEAD/H-box helicase 11, transcript variant X2
DEAD/H-box helicase 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ATP-dependent DNA helicase DDX11 isoform X1
ATP-dependent DNA helicase DDX11 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: pre-mRNA-splicing factor SPF27-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: IQ motif and SEC7 domain-containing protein 3
solute carrier family 6 member 12, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 6 member 12, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 6 member 12, transcript variant X2
solute carrier family 6 member 12, transcript variant X1
solute carrier family 6 member 12, transcript variant X4
sodium- and chloride-dependent betaine transporter isoform X2
sodium- and chloride-dependent betaine transporter isoform X1
sodium- and chloride-dependent betaine transporter isoform X3
solute carrier family 6 member 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 6 member 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
sodium- and chloride-dependent GABA transporter 2 isoform X1
sodium- and chloride-dependent GABA transporter 2 isoform X2
lysine demethylase 5A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
lysine-specific demethylase 5A isoform X1
lysine demethylase 5A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
lysine-specific demethylase 5A isoform X2
coiled-coil domain containing 77, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
coiled-coil domain containing 77, transcript variant X2
coiled-coil domain containing 77, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
coiled-coil domain-containing protein 77
beta-1,4-N-acetyl-galactosaminyltransferase 3, transcript variant X2
beta-1,4-N-acetyl-galactosaminyltransferase 3, transcript variant X1
beta-1,4-N-acetylgalactosaminyltransferase 3 isoform X1
beta-1,4-N-acetylgalactosaminyltransferase 3 isoform X2
uncharacterized LOC106728928, transcript variant X2
uncharacterized LOC106728928, transcript variant X1
uncharacterized LOC106728927, transcript variant X4
uncharacterized LOC106728927, transcript variant X2
uncharacterized LOC106728927, transcript variant X3
uncharacterized LOC106728927, transcript variant X1
WNK lysine deficient protein kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X2
WNK lysine deficient protein kinase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X7
WNK lysine deficient protein kinase 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X11
WNK lysine deficient protein kinase 1, transcript variant X12
WNK lysine deficient protein kinase 1, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X3
WNK lysine deficient protein kinase 1, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X13
WNK lysine deficient protein kinase 1, transcript variant X17
WNK lysine deficient protein kinase 1, transcript variant X6
WNK lysine deficient protein kinase 1, transcript variant X14
WNK lysine deficient protein kinase 1, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
WNK lysine deficient protein kinase 1, transcript variant X8
serine/threonine-protein kinase WNK1 isoform X1
serine/threonine-protein kinase WNK1 isoform X4
serine/threonine-protein kinase WNK1 isoform X9
serine/threonine-protein kinase WNK1 isoform X2
serine/threonine-protein kinase WNK1 isoform X5
serine/threonine-protein kinase WNK1 isoform X7
serine/threonine-protein kinase WNK1 isoform X10
serine/threonine-protein kinase WNK1 isoform X11
serine/threonine-protein kinase WNK1 isoform X12
serine/threonine-protein kinase WNK1 isoform X16
serine/threonine-protein kinase WNK1 isoform X3
serine/threonine-protein kinase WNK1 isoform X15
serine/threonine-protein kinase WNK1 isoform X13
serine/threonine-protein kinase WNK1 isoform X17
serine/threonine-protein kinase WNK1 isoform X6
serine/threonine-protein kinase WNK1 isoform X14
serine/threonine-protein kinase WNK1 isoform X19
serine/threonine-protein kinase WNK1 isoform X8
WNK lysine deficient protein kinase 1, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein kinase WNK1 isoform X18
RAD52 homolog, DNA repair protein, transcript variant X7
RAD52 homolog, DNA repair protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RAD52 homolog, DNA repair protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RAD52 homolog, DNA repair protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RAD52 homolog, DNA repair protein, transcript variant X3
RAD52 homolog, DNA repair protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RAD52 homolog, DNA repair protein, transcript variant X8
RAD52 homolog, DNA repair protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
RAD52 homolog, DNA repair protein, transcript variant X9
DNA repair protein RAD52 homolog isoform X2
DNA repair protein RAD52 homolog isoform X3
DNA repair protein RAD52 homolog isoform X1
DNA repair protein RAD52 homolog isoform X4
ELKS/RAB6-interacting/CAST family member 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
LOW QUALITY PROTEIN: ELKS/Rab6-interacting/CAST family member 1
Wnt family member 5B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
F-box and leucine rich repeat protein 14, transcript variant X2
F-box and leucine rich repeat protein 14, transcript variant X1
F-box and leucine rich repeat protein 14, transcript variant X3
Wnt family member 5B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Wnt family member 5B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC116661373, transcript variant X1
uncharacterized LOC116661373, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
adiponectin receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X6
adiponectin receptor 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
adiponectin receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adiponectin receptor protein 2 isoform X1
adiponectin receptor protein 2 isoform X2
adiponectin receptor protein 2 isoform X3
calcium voltage-gated channel auxiliary subunit alpha2delta 4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: voltage-dependent calcium channel subunit alpha-2/delta-4
leucine rich repeats and transmembrane domains 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: leucine-rich repeat and transmembrane domain-containing protein 2
uncharacterized LOC116661351, transcript variant X2
uncharacterized LOC116661351, transcript variant X1
uncharacterized protein LOC116661351 isoform X1
uncharacterized protein LOC116661351 isoform X2
decapping mRNA 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
decapping mRNA 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 C
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 24 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: voltage-dependent L-type calcium channel subunit alpha-1C
gap junction beta-3 protein-like protein, transcript variant X18
gap junction beta-3 protein-like protein, transcript variant X15
gap junction beta-3 protein-like protein, transcript variant X17
gap junction beta-3 protein-like protein, transcript variant X14
gap junction beta-3 protein-like protein, transcript variant X12
gap junction beta-3 protein-like protein, transcript variant X10
gap junction beta-3 protein-like protein, transcript variant X8
gap junction beta-3 protein-like protein, transcript variant X16
gap junction beta-3 protein-like protein, transcript variant X13
gap junction beta-3 protein-like protein, transcript variant X9
gap junction beta-3 protein-like protein, transcript variant X11
gap junction beta-3 protein-like protein, transcript variant X4
gap junction beta-3 protein-like protein, transcript variant X6
gap junction beta-3 protein-like protein, transcript variant X7
gap junction beta-3 protein-like protein, transcript variant X5
gap junction beta-3 protein-like protein, transcript variant X1
gap junction beta-3 protein-like protein, transcript variant X2
gap junction beta-3 protein-like protein, transcript variant X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
LOW QUALITY PROTEIN: interleukin-17 receptor A
uncharacterized LOC106728867, transcript variant X3
uncharacterized LOC106728867, transcript variant X1
uncharacterized LOC106728867, transcript variant X2
transmembrane protein 121B, transcript variant X1
transmembrane protein 121B, transcript variant X2
haloacid dehalogenase like hydrolase domain containing 5
haloacid dehalogenase-like hydrolase domain-containing 5
adenosine deaminase 2, transcript variant X5
adenosine deaminase 2, transcript variant X1
adenosine deaminase 2, transcript variant X4
adenosine deaminase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
adenosine deaminase 2, transcript variant X6
adenosine deaminase 2, transcript variant X3
adenosine deaminase 2, transcript variant X2
adenosine deaminase 2, transcript variant X8
cat eye syndrome critical region protein 2, transcript variant X1
cat eye syndrome critical region protein 2 isoform X1
cat eye syndrome critical region protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cat eye syndrome critical region protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
BH3 interacting domain death agonist, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
BH3 interacting domain death agonist, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
BH3 interacting domain death agonist, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
BH3-interacting domain death agonist isoform X2
BH3-interacting domain death agonist isoform X1
BH3 interacting domain death agonist, transcript variant X4
BH3-interacting domain death agonist isoform X3
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X3
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X9
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X11
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X10
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X12
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X6
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X22
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X18
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X17
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X19
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X24
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X27
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X8
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X15
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X21
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X30
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X32
F-actin-monooxygenase MICAL3 isoform X27
F-actin-monooxygenase MICAL3 isoform X26
F-actin-monooxygenase MICAL3 isoform X25
F-actin-monooxygenase MICAL3 isoform X21
F-actin-monooxygenase MICAL3 isoform X19
F-actin-monooxygenase MICAL3 isoform X16
F-actin-monooxygenase MICAL3 isoform X24
F-actin-monooxygenase MICAL3 isoform X10
F-actin-monooxygenase MICAL3 isoform X23
F-actin-monooxygenase MICAL3 isoform X15
F-actin-monooxygenase MICAL3 isoform X11
F-actin-monooxygenase MICAL3 isoform X18
F-actin-monooxygenase MICAL3 isoform X17
F-actin-monooxygenase MICAL3 isoform X13
F-actin-monooxygenase MICAL3 isoform X14
F-actin-monooxygenase MICAL3 isoform X12
F-actin-monooxygenase MICAL3 isoform X28
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X20
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X16
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
F-actin-monooxygenase MICAL3 isoform X20
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
F-actin-monooxygenase MICAL3 isoform X22
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X29
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X33
F-actin-monooxygenase MICAL3 isoform X29
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X34
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X35
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
F-actin-monooxygenase MICAL3 isoform X30
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X37
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
F-actin-monooxygenase MICAL3 isoform X31
microtubule associated monooxygenase, calponin and LIM domain containing 3, transcript variant X38
F-actin-monooxygenase MICAL3 isoform X32
uncharacterized LOC106728866, transcript variant X2
uncharacterized LOC106728866, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments